Pendal Group’s Guardant Health GH Stock Holding History

Pendal Group’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,468	Closed	-$230K	–	477
2022 Q1	$230K	Hold	3,468	–	–	﹤0.01%	472
2021 Q4	$347K	Hold	3,468	–	–	﹤0.01%	467
2021 Q3	$434K	Buy	3,468 +50	+1%	+$5.94K	﹤0.01%	429
2021 Q2	$424K	Sell	3,418 -72	-2%	-$9.68K	﹤0.01%	428
2021 Q1	$533K	Sell	3,490 -1,575	-31%	-$238K	0.01%	400
2020 Q4	$653K	Hold	5,065	–	–	0.01%	348
2020 Q3	$566K	Buy	5,065 +200	+4%	+$18.3K	0.01%	306
2020 Q2	$395K	Buy	4,865 +2,789	+134%	+$225K	0.01%	346
2020 Q1	$144K	Sell	2,076 -3,870	-65%	-$297K	﹤0.01%	354
2019 Q4	$465K	Buy	5,946 +1,101	+23%	+$79.3K	0.01%	320
2019 Q3	$309K	Hold	4,845	–	–	﹤0.01%	392
2019 Q2	$418K	Buy	4,845 +390	+9%	+$29.8K	0.01%	359
2019 Q1	$342K	Sell	4,455 -1,210	-21%	-$67.1K	﹤0.01%	388
2018 Q4	$213K	Buy	+5,665	New	+$209K	﹤0.01%	384

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Pendal Group's GH Position: Q2 2022 in Review

Pendal Group sold out of Guardant Health (GH) in Q2 2022, closing a stake of 3,468 shares — an estimated $230K sold.

Pendal Group first reported a position in GH in Q4 2018 and held it in 14 quarters. The position peaked at $653K in Q4 2020. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

Pendal Group reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
Pendal Group sold 3,468 Guardant Health shares in Q2 2022, an estimated $230K.
Pendal Group first reported a position in Guardant Health in Q4 2018 and held it in 14 quarters.
Pendal Group's Guardant Health position peaked at $653K in Q4 2020.
332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Pendal Group's 13F filing for Q2 2022, filed 25 Jul 2022.